Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. PRYMY
3. SPY
4. ALAR
5. CCH:LN
6. META
7. CCHGY
8. PRY:IM
9. WIZZ:LN
10. FFAI

Go back to Kiora Pharmaceuticals Reports Additional Clinical Data for KIO-301 Showing a Statistically Significant Increase in Brain Activity in the Visual Cortex in Patients with Retinitis Pigmentosa
(NASDAQ: KPRX) Delayed: 2.63 -0.03 (1.13%)
Previous Close $2.66    52 Week High $ 
Open $2.68    52 Week Low $ 
Day High $2.74    P/E N/A 
Day Low $2.62    EPS $ 
Volume 8,964